ADAR1 Capital Management’s iBio IBIO Stock Holding History

ADAR1 Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$893K	Buy	469,878 +64,347	+16%	+$149K	0.05%	171
2025 Q4	$783K	Buy	405,531 +378,531	+1,402%	+$517K	0.06%	153
2025 Q3	$22.4K	Sell	27,000 -27,819	-51%	-$21.4K	﹤0.01%	212
2025 Q2	$41.8K	Buy	+54,819	New	+$59.5K	0.01%	193
2025 Q1	–	Sell	-415,606	Closed	-$1.02M	–	229
2024 Q4	$1.02M	Sell	415,606 -60,606	-13%	-$156K	0.2%	75
2024 Q3	$1.06M	Sell	476,212 -93,788	-16%	-$185K	0.17%	71
2024 Q2	$1.2M	Sell	570,000 -30,000	-5%	-$64.5K	0.23%	59
2024 Q1	$2.19M	Buy	+600,000	New	+$754K	0.5%	39

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ADAR1 Capital Management's IBIO Position: Q1 2026 in Review

ADAR1 Capital Management increased its iBio (IBIO) stake by 16% in Q1 2026, buying an estimated $149K and bringing the position to 469,878 shares worth $893K. The position accounts for 0.05% of the portfolio, ranked #171.

ADAR1 Capital Management first reported a position in IBIO in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.19M in Q1 2024. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

ADAR1 Capital Management held 469,878 shares of iBio worth $893K as of Q1 2026.
ADAR1 Capital Management bought 64,347 iBio shares in Q1 2026, an estimated $149K.
iBio made up 0.05% of ADAR1 Capital Management's portfolio in Q1 2026, its #171 holding.
ADAR1 Capital Management first reported a position in iBio in Q1 2024 and has held it in 8 quarters since.
ADAR1 Capital Management's iBio position peaked at $2.19M in Q1 2024.
52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.